Multifaceted applications of nanomaterials in cell engineering and therapy

Biotechnology Advances

Volumn 31, Issue 5, 2013, Pages 638-653

  Chen, Hui ^a   Zeng, Yang ^a   Liu, Wei ^a   Zhao, Shan ^a   Wu, Jinhui ^b   Du, Yanan ^a  

^a Tsinghua University   (China)

^b NANJING UNIVERSITY   (China)

Author keywords

Cell engineering; Cell therapy; Nanomaterials; Regenerative medicine

Indexed keywords

CELL POPULATIONS; CELL THERAPY; CLINICAL MEDICINE; DISEASE MODELS; DYNAMIC FIELDS; EMERGING TRENDS; PHYSIO-CHEMICAL PROPERTIES; REGENERATIVE MEDICINE;

CELL CULTURE; CELL ENGINEERING; CELL PROLIFERATION; CELLS; MEDICINE; NANOSTRUCTURED MATERIALS; TISSUE;

DISEASE CONTROL;

NANOMATERIAL;

CYTOLOGY; NANOTECHNOLOGY; PHYSICOCHEMICAL PROPERTY;

ANIMAL; CELL ENGINEERING; CHEMISTRY; CYTOLOGY; EMBRYONIC STEM CELL; HUMAN; METHODOLOGY; REGENERATIVE MEDICINE; REVIEW; STEM CELL TRANSPLANTATION;

ANIMALS; CELL ENGINEERING; EMBRYONIC STEM CELLS; HUMANS; NANOSTRUCTURES; REGENERATIVE MEDICINE; STEM CELL TRANSPLANTATION;

EID: 84879409298     PISSN: 07349750     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biotechadv.2012.08.002     Document Type: Review

References (108)

1. Airey J.A., Almeida-Porada G., Colletti E.J., Porada C.D., Chamberlain J., Movsesian M., et al. Human mesenchymal stem cells form Purkinje fibers in fetal sheep heart. Circulation 2004, 109:1401-1407.
2. Alvarez-Erviti L., Seow Y., Yin H., Betts C., Lakhal S., Wood M.J. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol 2011, 29:341-345.
3. Berthiaume F., Moghe P.V., Toner M., Yarmush M.L. Effect of extracellular matrix topology on cell structure, function, and physiological responsiveness: hepatocytes cultured in a sandwich configuration. FASEB J 1996, 10:1471-1484.
4. Blundell J. Experiments on the transfusion of blood by the syringe. Med Chir Trans 1818, 9:56-92.
5. Caplan A.I. Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J Cell Physiol 2007, 213:341-347.
6. Carlberg B., Axell M.Z., Kuhn H.G. Electrospun polyurethane scaffolds for proliferation and neuronal differentiation of human embryonic stem cells. Biomed Mater 2009, 4.
7. Carlberg B., Axell M.Z., Nannmark U., Liu J., Kuhn H.G. Electrospun polyurethane scaffolds for proliferation and neuronal differentiation of human embryonic stem cells. Biomed Mater 2009, 4:045004.
8. Chai C., Leong K.W. Biomaterials approach to expand and direct differentiation of stem cells. Mol Ther 2007, 15:467-480.
9. Chan B.P., Hui T.Y., Yeung C.W., Li J., Mo I., Chan G.C. Self-assembled collagen-human mesenchymal stem cell microspheres for regenerative medicine. Biomaterials 2007, 28:4652-4666.
10. Chen H., Li X., Du Y. 1D~3D Nano-engineered Materials for Biomedical Application. Integrated Biomaterials for Medical Applications 2012, 2-44. VBRI Press. M. Ramalingam, A. Tiwari (Eds.).
11. Choi M.R., Stanton-Maxey K.J., Stanley J.K., Levin C.S., Bardhan R., Akin D., et al. A cellular Trojan Horse for delivery of therapeutic nanoparticles into tumors. Nano Lett 2007, 7:3759-3765.
12. Collins MiaC, Joel L., Moore J., Burrows B.J., Kypson A.P., Mulle-Borer B.J. Early cell loss associated with mesenchymal stem cell cardiomyoplasty. J Tissue Eng Regen Med 2012, 17-24.
13. Dalby M.J., Gadegaard N., Tare R., Andar A., Riehle M.O., Herzyk P., et al. The control of human mesenchymal cell differentiation using nanoscale symmetry and disorder. Nat Mater 2007, 6:997-1003.
14. De Coppi P., Bartsch G., Siddiqui M.M., Xu T., Santos C.C., Perin L., et al. Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol 2007, 25:100-106.
15. de Vries W.N., Evsikov A.V., Brogan L.J., Anderson C.P., Graber J.H., Knowles B.B., et al. Reprogramming and differentiation in mammals: motifs and mechanisms. Cold Spring Harb Symp Quant Biol 2008, 73:33-38.
16. Devine M.J., Ryten M., Vodicka P., Thomson A.J., Burdon T., Houlden H., et al. Parkinson's disease induced pluripotent stem cells with triplication of the alpha-synuclein locus. Nat Commun 2011, 2:440.
17. Dou H., Destache C.J., Morehead J.R., Mosley R.L., Boska M.D., Kingsley J., et al. Development of a macrophage-based nanoparticle platform for antiretroviral drug delivery. Blood 2006, 108:2827-2835.
18. Douglas S.M., Bachelet I., Church G.M. A logic-gated nanorobot for targeted transport of molecular payloads. Science 2012, 335:831-834.
19. Du Y., Lo E., Ali S., Khademhosseini A. Directed assembly of cell-laden microgels for fabrication of 3D tissue constructs. Proc Natl Acad Sci U S A 2008, 105:9522-9527.
20. Fong C.Y., Peh G.S., Gauthaman K., Bongso A. Separation of SSEA-4 and TRA-1-60 labelled undifferentiated human embryonic stem cells from a heterogeneous cell population using magnetic-activated cell sorting (MACS) and fluorescence-activated cell sorting (FACS). Stem Cell Rev 2009, 5:72-80.
21. Gimble J.M., Katz A.J., Bunnell B.A. Adipose-derived stem cells for regenerative medicine. Circ Res 2007, 100:1249-1260.
22. Grskovic M., Javaherian A., Strulovici B., Daley G.Q. Induced pluripotent stem cells - opportunities for disease modelling and drug discovery. Nat Rev Drug Discov 2011, 10:915-929.
23. Hacking A., Du Y., Khademhosseini Ali Polymer patterning for biological application. Comprehensive Polymer Science 2012, 439-456. Elsevier. M. Moeller, K. Matyjaszewski (Eds.).
24. Han D., Gouma P.I. Electrospun bioscaffolds that mimic the topology of extracellular matrix. Nanomedicine 2006, 2:37-41.
25. Han S.W., Nakamura C., Kotobuki N., Obataya I., Ohgushi H., Nagamune T., et al. High-efficiency DNA injection into a single human mesenchymal stem cell using a nanoneedle and atomic force microscopy. Nanomedicine 2008, 4:215-225.
26. Hargus G., Cooper O., Deleidi M., Levy A., Lee K., Marlow E., et al. Differentiated Parkinson patient-derived induced pluripotent stem cells grow in the adult rodent brain and reduce motor asymmetry in Parkinsonian rats. Proc Natl Acad Sci U S A 2010, 107:15921-15926.
27. Huang Z.M., Zhang Y.Z., Kotaki M., Ramakrishna S. A review on polymer nanofibers by electrospinning and their applications in nanocomposites. Compos Sci Technol 2003, 63:2223-2253.
28. Ieda M., Fu J.D., Delgado-Olguin P., Vedantham V., Hayashi Y., Bruneau B.G., et al. Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell 2010, 142:375-386.
29. Itzhaki I., Maizels L., Huber I., Zwi-Dantsis L., Caspi O., Winterstern A., et al. Modelling the long QT syndrome with induced pluripotent stem cells. Nature 2011, 471:225-229.
30. Jayawardena T.M., Egemnazarov B., Finch E.A., Zhang L., Payne J.A., Pandya K., et al. MicroRNA-mediated in vitro and in vivo direct reprogramming of cardiac fibroblasts to cardiomyocytes. Circ Res 2012, 110:1465-1473.
31. Jeon S.Y., Park J.S., Yang H.N., Woo D.G., Park K.H. Co-delivery of SOX9 genes and anti-Cbfa-1 siRNA coated onto PLGA nanoparticles for chondrogenesis of human MSCs. Biomaterials 2012, 33:4413-4423.
32. Jungebluth P., Macchiarini P. Stem cell-based therapy and regenerative approaches to diseases of the respiratory system. Br Med Bull 2011, 99:169-187.
33. Karp J.M., Leng Teo G.S. Mesenchymal stem cell homing: the devil is in the details. Cell Stem Cell 2009, 4:206-216.
34. Karussis D., Karageorgiou C., Vaknin-Dembinsky A., Gowda-Kurkalli B., Gomori J.M., Kassis I., et al. Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis. Arch Neurol 2010, 67:1187-1194.
35. Keller G. Embryonic stem cell differentiation: emergence of a new era in biology and medicine. Genes Dev 2005, 19:1129-1155.
36. Kim W., Ng J.K., Kunitake M.E., Conklin B.R., Yang P. Interfacing silicon nanowires with mammalian cells. J Am Chem Soc 2007, 129:7228-7229.
37. Kim P., Du Y., Khademhosseini A., Langer R., Suh K.Y. Unconventional patterning methods for BioNEMS. Nanopatterning and Applications 2009, 325-358. Wiley. J.A. Rogers, H.H. Lee (Eds.).
38. Kim D.H., Lipke E.A., Kim P., Cheong R., Thompson S., Delannoy M., et al. Nanoscale cues regulate the structure and function of macroscopic cardiac tissue constructs. Proc Natl Acad Sci U S A 2010, 107:565-570.
39. Kim K.S., Khang G., Lee D. Application of nanomedicine in cardiovascular diseases and stroke. Curr Pharm Des 2011, 17:1825-1833.
40. Kuhara M., Takeyama H., Tanaka T., Matsunaga T. Magnetic cell separation using antibody binding with protein A expressed on bacterial magnetic particles. Anal Chem 2004, 76:6207-6213.
41. Kulangara K., Yang Y., Yang J., Leong K.W. Nanotopography as modulator of human mesenchymal stem cell function. Biomaterials 2012, 33:4998-5003.
42. Kyrtatos P.G., Lehtolainen P., Junemann-Ramirez M., Garcia-Prieto A., Price A.N., Martin J.F., et al. Magnetic tagging increases delivery of circulating progenitors in vascular injury. JACC Cardiovasc Interv 2009, 2:794-802.
43. Lai R.C., Chen T.S., Lim S.K. Mesenchymal stem cell exosome: a novel stem cell-based therapy for cardiovascular disease. Regen Med 2011, 6:481-492.
44. Laurent S., Forge D., Port M., Roch A., Robic C., Vander Elst L., et al. Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. Chem Rev 2008, 108:2064-2110.
45. Lavik E., von Recum H. The role of nanomaterials in translational medicine. ACS Nano 2011, 5:3419-3424.
46. Lee M.R., Kwon K.W., Jung H., Kim H.N., Suh K.Y., Kim K., et al. Direct differentiation of human embryonic stem cells into selective neurons on nanoscale ridge/groove pattern arrays. Biomaterials 2010, 31:4360-4366.
47. Lee J.B., Hong J., Bonner D.K., Poon Z., Hammond P.T. Self-assembled RNA interference microsponges for efficient siRNA delivery. Nat Mater 2012, 11:316-322.
48. Lei Y., Tang H., Yao L., Yu R., Feng M., Zou B. Applications of mesenchymal stem cells labeled with Tat peptide conjugated quantum dots to cell tracking in mouse body. Bioconjug Chem 2008, 19:421-427.
49. Li X., wittkowske C., Yao R., Du Y. Hydrogel as stem cell niche for in vivo applications in regenerative medicine. Biomaterials and Stem Cells in Regenerative Medicine 2012, 31-54. CRC Press, Boca Raton. M. Ramalingam, S. Ramakrishna, S. Best (Eds.).
50. Liao S., Chan C.K., Ramakrishna S. Electrospun nanofibers: Work for medicine?. Front Mater Sci China 2010, 4:29-33.
51. Lim S.H., Mao H.Q. Electrospun scaffolds for stem cell engineering. Adv Drug Deliv Rev 2009, 61:1084-1096.
52. Liu X., Jin X., Ma P.X. Nanofibrous hollow microspheres self-assembled from star-shaped polymers as injectable cell carriers for knee repair. Nat Mater 2011, 10:398-406.
53. Lukianova-Hleb E., Hu Y., Latterini L., Tarpani L., Lee S., Drezek R.A., et al. Plasmonic nanobubbles as transient vapor nanobubbles generated around plasmonic nanoparticles. ACS Nano 2010, 4:2109-2123.
54. Lukianova-Hleb E.Y., Wagner D.S., Brenner M.K., Lapotko D.O. Cell-specific transmembrane injection of molecular cargo with gold nanoparticle-generated transient plasmonic nanobubbles. Biomaterials 2012, 33:5441-5450.
55. Mammadov R., Mammadov B., Toksoz S., Aydin B., Yagci R., Tekinay A.B., et al. Heparin mimetic peptide nanofibers promote angiogenesis. Biomacromolecules 2011, 12:3508-3519.
56. Martino S., di Girolamo I., Tiribuzi R., D'Angelo F., Datti A., Orlacchio A. Efficient siRNA delivery by the cationic liposome DOTAP in human hematopoietic stem cells differentiating into dendritic cells. J Biomed Biotechnol 2009, 2009:410260.
57. Marx J.L. Virus 1991, Grolier, New York.
58. Mason C., Dunnill P. A brief definition of regenerative medicine. Regen Med 2008, 3:1-5.
59. Maury Y., Gauthier M., Peschanski M., Martinat C. Human pluripotent stem cells for disease modelling and drug screening. Bioessays 2012, 34:61-71.
60. McMurray R.J., Gadegaard N., Tsimbouri P.M., Burgess K.V., McNamara L.E., Tare R., et al. Nanoscale surfaces for the long-term maintenance of mesenchymal stem cell phenotype and multipotency. Nat Mater 2011, 10:637-644.
61. Mimeault M., Hauke R., Batra S.K. Stem cells: a revolution in therapeutics-recent advances in stem cell biology and their therapeutic applications in regenerative medicine and cancer therapies. Clin Pharmacol Ther 2007, 82:252-264.
62. Na H.B., Song I.C., Hyeon T. Inorganic nanoparticles for MRI contrast agents. Adv Mater 2009, 21:2133-2148.
63. Narayan A.D., Chase J.L., Lewis R.L., Tian X., Kaufman D.S., Thomson J.A., et al. Human embryonic stem cell-derived hematopoietic cells are capable of engrafting primary as well as secondary fetal sheep recipients. Blood 2006, 107:2180-2183.
64. Nie S. Biomedical nanotechnology for molecular imaging, diagnostics, and targeted therapy. Conf Proc IEEE Eng Med Biol Soc 2009, 2009:4578-4579.
65. Okita K., Ichisaka T., Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature 2007, 448:313-317.
66. Panyam J., Labhasetwar V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Deliv Rev 2003, 55:329-347.
67. Pegtel D.M., Cosmopoulos K., Thorley-Lawson D.A., van Eijndhoven M.A., Hopmans E.S., Lindenberg J.L., et al. Functional delivery of viral miRNAs via exosomes. Proc Natl Acad Sci U S A 2010, 107:6328-6333.
68. Peran M., Garcia M.A., Lopez-Ruiz E., Bustamante M., Jimenez G., Madeddu R., et al. Functionalized nanostructures with application in regenerative medicine. Int J Mol Sci 2012, 13:3847-3886.
69. Qi H., Du Y., Wang L., Kaji H., Bae H., Khademhosseini A. Patterned differentiation of individual embryoid bodies in spatially organized 3D hybrid microgels. Adv Mater 2010, 22:5276-5281.
70. Qian L., Huang Y., Spencer C.I., Foley A., Vedantham V., Liu L., et al. In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes. Nature 2012, 485:593-598.
71. Rothemund P.W. Folding DNA to create nanoscale shapes and patterns. Nature 2006, 440:297-302.
72. Schaffer D.V., Koerber J.T., Lim K.I. Molecular engineering of viral gene delivery vehicles. Annu Rev Biomed Eng 2008, 10:169-194.
73. Schroeder A., Goldberg M.S., Kastrup C., Wang Y., Jiang S., Joseph B.J., et al. Remotely activated protein-producing nanoparticles. Nano Lett 2012, 12:2685-2695.
74. Seow Y., Wood M.J. Biological gene delivery vehicles: beyond viral vectors. Mol Ther 2009, 17:767-777.
75. Shah B.S., Clark P.A., Moioli E.K., Stroscio M.A., Mao J.J. Labeling of mesenchymal stem cells by bioconjugated quantum dots. Nano Lett 2007, 7:3071-3079.
76. Shao L., Wu W.S. Gene-delivery systems for iPS cell generation. Expert Opin Biol Ther 2010, 10:231-242.
77. Slaughter B.V., Khurshid S.S., Fisher O.Z., Khademhosseini A., Peppas N.A. Hydrogels in regenerative medicine. Adv Mater 2009, 21:3307-3329.
78. Smith L.A., Liu X., Hu J., Ma P.X. The influence of three-dimensional nanofibrous scaffolds on the osteogenic differentiation of embryonic stem cells. Biomaterials 2009, 30:2516-2522.
79. Stanley S.A., Gagner J.E., Damanpour S., Yoshida M., Dordick J.S., Friedman J.M. Radio-wave heating of iron oxide nanoparticles can regulate plasma glucose in mice. Science 2012, 336:604-608.
80. Stephan M.T., Irvine D.J. Enhancing Cell Therapies from the Outside. Nano Today 2011, 6:309-325.
81. Stephan M.T., Moon J.J., Um S.H., Bershteyn A., Irvine D.J. Therapeutic cell engineering with surface-conjugated synthetic nanoparticles. Nat Med 2010, 16:1035-1041.
82. Stevens M.M., George J.H. Exploring and engineering the cell surface interface. Science 2005, 310:1135-1138.
83. Strauer B.E., Kornowski R. Stem cell therapy in perspective. Circulation 2003, 107:929-934.
84. Suzuki T., Yokoyama Y., Kumano K., Takanashi M., Kozuma S., Takato T., et al. Highly efficient ex vivo expansion of human hematopoietic stem cells using Delta1-Fc chimeric protein. Stem Cells 2006, 24:2456-2465.
85. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676.
86. Terrovitis J.V., Smith R.R., Marbán E. Assessment and optimization of cell engraftment after transplantation into the heart. Circ Res 2010, 106:479-494.
87. Tiscornia G., Vivas E.L., Belmonte J.C. Diseases in a dish: modeling human genetic disorders using induced pluripotent cells. Nat Med 2011, 17:1570-1576.
88. Valadi H., Ekstrom K., Bossios A., Sjostrand M., Lee J.J., Lotvall J.O. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 2007, 9:654-659.
89. Vauthey S., Santoso S., Gong H., Watson N., Zhang S. Molecular self-assembly of surfactant-like peptides to form nanotubes and nanovesicles. Proc Natl Acad Sci U S A 2002, 99:5355-5360.
90. Verma S., Domb A.J., Kumar N. Nanomaterials for regenerative medicine. Nanomedicine (Lond) 2011, 6:157-181.
91. Wan A.C., Ying J.Y. Nanomaterials for in situ cell delivery and tissue regeneration. Adv Drug Deliv Rev 2010, 62:731-740.
92. 3 beads-CdSe/ZnS quantum dots core-shell nanocomposite particles for cell separation. Nano Lett 2004, 4:409-413.
93. Wang Z.Z., Au P., Chen T., Shao Y., Daheron L.M., Bai H., et al. Endothelial cells derived from human embryonic stem cells form durable blood vessels in vivo. Nat Biotechnol 2007, 25:317-318.
94. Webber M.J., Tongers J., Renault M.A., Roncalli J.G., Losordo D.W., Stupp S.I. Development of bioactive peptide amphiphiles for therapeutic cell delivery. Acta Biomater 2010, 6:3-11.
95. Wickline S.A., Lanza G.M. Nanotechnology for molecular imaging and targeted therapy. Circulation 2003, 107:1092-1095.
96. Wray P. 'Cotton candy' that heals. Am Ceram Soc Bull 2011, 90:25-29.
97. Xia Y. Nanomaterials at work in biomedical research. Nat Mater 2008, 7:758-760.
98. Xin H., Li Y., Buller B., Katakowski M., Zhang Y., Wang X.L., et al. Exosome mediated transfer of miR-133b from multipotent mesenchymal stromal cells to neural cells contributes to neurite outgrowth. Stem Cells 2012, 30:1556-1564.
99. Xu Y., Shi Y., Ding S. A chemical approach to stem-cell biology and regenerative medicine. Nature 2008, 453:338-344.
100. Xu C., Mu L., Roes I., Miranda-Nieves D., Nahrendorf M., Ankrum J.A., et al. Nanoparticle-based monitoring of cell therapy. Nanotechnology 2011, 22:494001.
101. Xu C., Miranda-Nieves D., Ankrum J.A., Matthiesen M.E., Phillips J.A., Roes I., et al. Tracking mesenchymal stem cells with iron oxide nanoparticle loaded poly(lactide-co-glycolide) microparticles. Nano Lett 2012, 12:4131-4139.
102. Xu H, Yi BA, Chien KR. In vivo reprogramming for heart disease. Cell Res in press. http://dx.doi.org/10.1038/cr.2012.101.
103. Yang F., Cho S.W., Son S.M., Bogatyrev S.R., Singh D., Green J.J., et al. Genetic engineering of human stem cells for enhanced angiogenesis using biodegradable polymeric nanoparticles. Proc Natl Acad Sci 2009, 107:3317-3322.
104. Yoshino T., Hirabe H., Takahashi M., Kuhara M., Takeyama H., Matsunaga T. Magnetic cell separation using nano-sized bacterial magnetic particles with reconstructed magnetosome membrane. Biotechnol Bioeng 2008, 101:470-477.
105. Zhang L., Webster T.J. Nanotechnology and nanomaterials: promises for improved tissue regeneration. Nano Today 2009, 4:66-80.
106. Zhang J., Lian Q., Zhu G., Zhou F., Sui L., Tan C., et al. A human iPSC model of Hutchinson Gilford Progeria reveals vascular smooth muscle and mesenchymal stem cell defects. Cell Stem Cell 2011, 8:31-45.
107. Zhao W., Schafer S., Choi J., Yamanaka Y.J., Lombardi M.L., Bose S., et al. Cell-surface sensors for real-time probing of cellular environments. Nat Nanotechnol 2011, 6:524-531.
108. Zou J., Sweeney C.L., Chou B.K., Choi U., Pan J., Wang H., et al. Oxidase-deficient neutrophils from X-linked chronic granulomatous disease iPS cells: functional correction by zinc finger nuclease-mediated safe harbor targeting. Blood 2011, 117:5561-5572.